BioSpace News Archive

Alcyone’s proprietary CNS precision delivery and dosing platform enables unprecedented control and versatility for CNS biodistribution and gene therapy development

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company pioneering novel cancer therapies, announced that nine abstracts have been selected for virtual presentation, including one oral presentation, at the upcoming European Hematology Association 2021 Virtual Congress taking place June 9-17, 2021.

CTI BioPharma Corp. announced that management will provide a corporate overview at the JMP Securities Life Sciences Conference at 2:30 p.m. ET.

Dr. Graff will lead IMV’s research to continue the expansion of DPX- based immuno-oncology pipeline and the development of a comprehensive translational strategy to optimize clinical success

Subtle Medical, a leading healthcare technology company using AI to improve the quality and efficiency of medical imaging, announced CE Mark for the second generation of their SubtlePET™ image enhancement technology demonstrating improved performance, more applicable PET radiotracers and extended coverage for additional clinical applications.

Inozyme Pharma, Inc. (Nasdaq: INZY), a rare disease biopharmaceutical company developing novel therapeutics for the treatment of abnormal mineralization, today announced the acceptance of its Clinical Trial Application (CTA) from the National Agency for the Safety of Medicines and Health Products (ANSM) in France to allow initiation of its Phase 1/2 clinical trial of INZ-701,

KemPharm, Inc., a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, announced its expected addition to the broad-market Russell 3000® Index and the Russell 2000® Index in accordance with the 2021 Russell indexes annual reconstitution.

CDR-Life Inc., a biotherapeutics company developing tumor-specific immunotherapies based on a proprietary antibody platform, announced the expansion of its leadership team with the appointment of Björn Peters as chief business officer.

Organicell Launches Autologous Blood Derived Platform PPX ™ – Patient Pure X ™

Vertigo is a medical condition, wherein a person feels he or she or the objects around are moving when they are not. The condition is often related to walking impairment, sweating, and nausea.